SLC5A2 and Hypoglycemia: Although this prediction equation focuses on drugs that tend to cause hypoglycemia, which is a risk factor for the development of CHD, some hypoglycemic drugs, such as SGLT2 inhibitors and GLP-1 receptor agonists, reduce the risk of CHD [24].